Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression.
Biomed Pharmacother
; 150: 112995, 2022 Jun.
Article
en En
| MEDLINE
| ID: mdl-35658243
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Profármacos
/
Neoplasias
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Biomed Pharmacother
Año:
2022
Tipo del documento:
Article